INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 170 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $48,116,000 | -33.2% | 442,854 | +1.3% | 0.01% | -36.4% |
| Q3 2016 | $71,981,000 | +21.3% | 437,337 | +5.2% | 0.01% | +10.0% |
| Q2 2016 | $59,328,000 | +12.1% | 415,814 | +0.9% | 0.01% | +11.1% |
| Q1 2016 | $52,930,000 | -14.7% | 412,001 | -0.8% | 0.01% | -10.0% |
| Q4 2015 | $62,036,000 | -8.1% | 415,376 | +2.1% | 0.01% | -16.7% |
| Q3 2015 | $67,505,000 | -19.2% | 406,997 | +17.6% | 0.01% | -7.7% |
| Q2 2015 | $83,529,000 | -9.9% | 346,048 | +5.2% | 0.01% | -7.1% |
| Q1 2015 | $92,744,000 | +86.4% | 328,856 | +3.1% | 0.01% | +75.0% |
| Q4 2014 | $49,755,000 | -31.7% | 318,941 | +3.6% | 0.01% | -33.3% |
| Q3 2014 | $72,875,000 | +2.9% | 307,894 | +2.8% | 0.01% | 0.0% |
| Q2 2014 | $70,839,000 | -8.5% | 299,364 | +27.5% | 0.01% | -7.7% |
| Q1 2014 | $77,412,000 | +1290.1% | 234,731 | +187.8% | 0.01% | +1200.0% |
| Q4 2013 | $5,569,000 | -3.7% | 81,567 | -2.6% | 0.00% | 0.0% |
| Q3 2013 | $5,780,000 | +83.1% | 83,728 | +19.0% | 0.00% | 0.0% |
| Q2 2013 | $3,156,000 | – | 70,379 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WHITE SQUARE CAPITAL LLP | 65,500 | $7,117,000 | 11.05% |
| Ghost Tree Capital, LLC | 70,000 | $7,606,000 | 1.83% |
| Carmignac Gestion | 2,022,792 | $219,776,000 | 1.71% |
| Orbimed Advisors | 1,120,000 | $121,688,000 | 1.55% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 29,555 | $3,211,000 | 1.45% |
| Parametrica Management Ltd | 10,814 | $1,175,000 | 1.16% |
| BB BIOTECH AG | 255,719 | $27,784,000 | 1.03% |
| SECTORAL ASSET MANAGEMENT INC | 74,150 | $8,056,000 | 0.89% |
| ALTRINSIC GLOBAL ADVISORS LLC | 188,904 | $20,524,000 | 0.76% |
| FALCON POINT CAPITAL, LLC | 45,005 | $4,890,000 | 0.66% |